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A B S T R A C T
By mapping the distribution of targeted plasmonic nanoparticles (NPs), photoacoustic (PA) imaging
offers the potential to detect the pathologies in the early stages. However, optical absorption of the
endogenous chromophores in the background tissue signiﬁcantly reduces the contrast resolution of
photoacoustic imaging. Previously, we introduced MPA imaging – a synergistic combination of magneto-
motive ultrasound (MMUS) and PA imaging, and demonstrated MPA contrast enhancement using cell
culture studies. In the current study, contrast enhancement was investigated in vivo using the magneto-
photo-acoustic (MPA) imaging augmented with dual-contrast nanoparticles. Liposomal nanoparticles
(LNPs) possessing both optical absorption and magnetic properties were injected into a murine tumor
model. First, photoacoustic signals were generated from both the endogenous absorbers in the tissue and
the liposomal nanoparticles in the tumor. Then, given signiﬁcant differences in magnetic properties of
tissue and LNPs, the magnetic response of LNPs (i.e. MMUS signal) was utilized to suppress the unwanted
PA signals from the background tissue thus improving the PA imaging contrast. In this study, we
demonstrated the 3D MPA imaging of LNP-labeled xenografted tumor in a live animal. Compared to
conventional PA imaging, the MPA imaging show signiﬁcantly enhanced contrast between the
nanoparticle-labeled tumor and the background tissue. Our results suggest the feasibility of MPA
imaging for high contrast in vivo mapping of dual-contrast nanoparticles.
 2014 The Authors. Published by Elsevier GmbH. 
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Molecular imaging has emerged in the past few years as a
technique capable of detecting the molecular signature of cancers
and monitoring the efﬁciency of targeted therapy [1]. In molecular
imaging, nanoparticles (NPs) designed to target particular tissues
or cells are used as molecular probes. The ability to image selected
molecular probes opens up a numerous exciting possibilities for
medical application, including the understanding of integrative
biology, the early detection and the characterization of cancers,
and the evaluation of treatment efﬁciency in a non-invasive
manner [1]. For most molecular imaging systems, the background
signal is a common problem, obscuring signals from speciﬁc probes
and limiting the detection sensitivity [2–4]. Therefore, contrast-Abbreviations: PA, photoacoustic; MMUS, magneto-motive ultrasound; MPA,
magneto-photo-acoustic; NPs, nanoparticles; LNPs, liposomal nanoparticles.
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Open access under CC BY-enhancement strategies are desired to improve the sensitivity and
speciﬁcity of molecular imaging in detecting the location, structure
and molecular processes of NP-targeted pathologies.
Photoacoustic (PA) imaging is a sensitive tool for studying living
systems [5–11]. PA imaging contrast is based on absorption of light
energy, provided by short pulsed lasers. The spatial resolution of
PA imaging is determined by ultrasound (US) imaging transducer
(typically less than 500 mm). In molecular PA imaging, plasmonic
NPs such as gold (Au) nanospheres [12] or nanorods (NRs) [13,14]
can be targeted to speciﬁc biomarkers of the disease, which allows
selective monitoring of pathologies at the cellular and molecular
level [15]. The PA pressure P(z) generated at a certain depth z using
laser illumination of wavelength l can be expressed as:
PðzÞ ¼ bC
2
CP
  !
maðlÞFðz; lÞ; (1)
where b is the thermal expansion coefﬁcient, C is the speed of
sound, CP is the heat capacity at a constant pressure, ma is the
optical absorption coefﬁcient, and F(z) is the laser ﬂuence at depth
z [16,17]. Given the constant laser input ﬂuence, the amplitude of
the photoacoustic signal is proportional to the absorber concen-
tration. PA imaging is usually conducted in the near-infrared (NIR)NC-ND license.
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of up to several centimeters. In general, although endogenous
chromophores in tissue (i.e. water, hemoglobin, melanin, and
lipids) have a lower optical absorption in the NIR region than
contrast agents, the volume of tissue and the concentration of
endogenous chromophores are much greater than that of the
contrast agent, making it difﬁcult for highly sensitive and speciﬁc
PA detection of the contrast agent in vivo. Therefore, for early
detection of pathologies such as cancer, approaches with enhanced
imaging contrast are needed.
To improve the contrast, a hybrid imaging technique, magneto-
photo-acoustic (MPA) imaging [18–21] or magnetomotive photo-
acoustic imaging [22,23], has been introduced based on the
integration of ultrasound, photoacoustic, and magneto-motive
ultrasound (MMUS) imaging. In MPA imaging, NPs with both
optical and magnetic properties were used as the imaging contrast
agent. Magneto-motive ultrasound imaging was used to suppress
undesired PA signals from the background tissue and, therefore to
improve the speciﬁc imaging contrast for dual-contrast nanopar-
ticles [18,21]. In MMUS imaging [24–26] the magnetic NPs
accumulated within the tissue were mechanically actuated by
an externally applied magnetic ﬁeld. The displacement that was
produced at the location of magnetic NPs can be detected using US
pulse-echo signals. The magneto-motive force F(z) on each
magnetic NP can be expressed as:
FðzÞ ¼ Vn p f mxn p
m0
Bz
@Bz
@z
; (2)
where Bz is the magnetic ﬂux density, m0 is the permeability
constant, Vnp, fm and xnp are the total size, the volumetric ratio, and
the volume magnetic susceptibility of magnetic nanoparticles,
respectively [27]. The contrast mechanism in MMUS imaging is
based on the signiﬁcant difference between the magnetic
susceptibility of normal tissue and that of the magnetic NPs.
Since magnetic susceptibility of typical magnetic NPs such as
magnetite (Fe3O4) is more than 6 orders of magnitude larger than
that of normal tissues, MMUS imaging was capable of differenti-
ating the magnetically labeled regions from the background tissue
with a high contrast.
However, MMUS imaging alone may not be able to identify the
local concentration variation of NPs within the labeled region [18].
When a magnetic ﬁeld was applied to a superparamagnetic NP in
the tissue, the interaction between the NP and the magnetic ﬁeld
generated a pulling force on the NP to move toward the lower
magnetic potential (i.e. magnetic coil). On the other hand, the
elasticity property of the tissues surrounding the NP provided
another force in opposite direction to restore the particle to its
original position. The displacement of the NP was a result of both
forces. Eq. (3) describes the motion of a particle within an inﬁnite
medium due to an external force. The displacement W of a
superparamagnetic NP can be calculated:
W ¼ Fð1 þ vÞð4z
2ð1 þ vÞ þ r2ð3 þ 4vÞÞ
8Epðr2 þ z2Þ3=2ð1 þ vÞ
; (3)
where z is the axial distance along the line of the magneto-motive
force, F is the magnitude of the magneto-motive force, r is the radial
distance from the central point of the applied force, E is the Young’s
modulus of the surrounding tissues, and v is the Poisson’s ratio
[28,29]. The MMUS image visualizes the combination of the
displacement induced by magneto-motive force on all the magnetic
nanoparticles within the labeled tissue. Based on Eq. (3), the
magnetically induced motion in the tissue is determined by not only
the NP distribution, but also the mechanical properties of
surrounding tissues [30]. Besides, the boundary condition of the
tissues makes the relationship between MMUS signal and NPconcentration even more complicated. Therefore, the MMUS
imaging is capable of distinguishing the magnetically labeled tumor
from the surrounding tissues based on the different magnetic
responses; however, MMUS imaging alone is not able to indicate the
local variation of NP concentration within the labeled tissue due to
the unknown mechanical properties of the surrounding tissues.
Using MMUS image as a complementary contrast, MPA imaging
was capable of suppressing the unwanted PA signals from the
background tissue and improving the contrast compared with
conventional PA imaging. Meanwhile, the magnitude of the
MMUS-masked PA signals was indicative of the concentration of
NPs thus indicates the distribution map of the nanoparticles. In this
study, MPA imaging was applied to detect the distribution of NPs in
a mouse in vivo with enhanced contrast. Liposomal nanoparticles
(LNPs) which encapsulated both Au NRs and Fe3O4 NPs were used
as a dual-contrast agent. A nude mouse bearing human epithelial
carcinoma (A431) was used to model the cancer. In order to test the
feasibility of MPA imaging in vivo, LNPs were injected directly into
the tumor; and MPA images were obtained by combining both
optical and magnetic responses from tissues. The contrast
enhancement in MPA imaging to detect the distribution of LNPs
in tissues compared to conventional PA imaging was investigated.
2. Materials and methods
2.1. Dual-contrast agent for MPA imaging
MPA imaging requires dual-contrast NPs that exhibit both
optical absorption in the NIR region and superparamagnetic
property. The LNPs were synthesized using the protocol published
previously [18,31]. Brieﬂy, three steps were needed to synthesize
the hybrid LNPs.
First, a lipid cake was formed on the inner wall of a pear-shaped
ﬂask by evaporating the solvent from a mixture of 1 mL of 10 mg/
mL egg phosphatidylcholine (Egg-PC) in chloroform (Avanti Polar
Lipids Inc.) and 0.11 mL of 10 mg/mL 1,2-dioleoyl-sn-glycero-3-
ethylphosphocholine (DOPC) in chloroform (Avanti Polar Lipids
Inc.) using a rotovap. Second, the lipid cake was hydrated with
3.7 mL 1X phosphate buffered saline (PBS) solution (Sigma–
Aldrich) containing 4.07 mg citrate-capped Fe3O4 NPs (7.5 nm)
and 4.37 mg Au NRs (9 nm  30 nm) [32], resulting in the
spontaneous formation of multi-lamellar liposomes (MLLs) with
encapsulated Fe3O4 NPs and Au NRs. Third, to control the size of the
hybrid nanoconstructs, the MLLs were subjected to a series of
freeze–thaw cycles to remove excess phospholipid bilayers from
the MLLs and extruded through a 200 nm polycarbonate mem-
brane (Avanti Polar Lipids Inc.).
The citrate-capped Fe3O4 NPs used in the second step were
obtained through a phase transfer reaction between tri(ethylene
glycol)-coated Fe3O4 NPs in ethanol and an aqueous solution of
14 mg/mL sodium citrate (Sigma–Aldrich) in nano-pure water. The
volume ratio between the tri(ethylene glycol)-coated Fe3O4
solution and the sodium citrate was 1:1. The tri(ethylene
glycol)-coated Fe3O4 NPs were synthesized by the thermal
decomposition of 1 g of iron (III) acetylacetonate (99.9% trace
metals basis, Sigma–Aldrich) in 20 mL tri(ethylene glycol) (Sigma–
Aldrich) at 250 8C for 4 h [33]. Prior to the phase transfer reaction,
the obtained tri(ethylene glycol)-coated Fe3O4 NPs were cleaned in
0.25 mL batches. A mixture of 0.25 mL Fe3O4 NPs, 0.75 mL ethanol,
and 1 mL ethyl acetate was centrifuged at 14,000  g for half an
hour. A black NP pellet was obtained after decanting the
supernatant. The cleaning step was repeated three times, and
the obtained pellet of cleaned Fe3O4 NPs was re-suspended in
0.25 mL ethanol. Then, the desired volumes of cleaned Fe3O4 NPs in
ethanol and the sodium citrate in water solution were mixed
together and shaken at 500 rpm overnight, allowing the phase
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glycol) surface layer was replaced with citrate ions. The citrate-
capped Fe3O4 NPs were obtained by centrifuging the reaction
solution in Millipore 50 kDa Amicon Ultra-15 Centrifugal Filter
Units at 3000  g for 15 min. The obtained NPs were re-suspended
with nano-pure water and re-ﬁltered four times. Finally the
ﬁltered citrate-capped Fe3O4 NPs were re-suspended in 1 PBS
solution.
The TEM image of synthesized LNPs was shown elsewhere [18].
Dynamic light scattering (DLS) analysis indicated that the empty
liposomes prepared using the same protocol had an average
diameter of 213.0 nm. The obtained LNPs were concentrated and
contained 2.36 mg/mL Au NRs and 2.2 mg/mL Fe3O4. The LNPs
provide dual-contrast for MPA imaging because they contain both
Au NRs, which absorb NIR light, and Fe3O4 NPs, which possess
strong magnetic susceptibility.
2.2. Animal model
To demonstrate the feasibility of MPA imaging to detect the
LNPs’ distribution in vivo with high contrast, a Nu/Nu mouse with a
xenografted tumor was used. The animal was inoculated
subcutaneously with 106 (100 mL injection volume) A431 human
epithelial carcinoma cells (American Type Culture Collection, VA).
When the tumors reached a diameter of 6–8 mm, 150 mL LNPs in
PBS was injected directly into the tumor. The LNPs contained
0.35 mg Au and 0.33 mg Fe3O4. MPA imaging was performed 2 h
after the injection of LNPs. During the 2 h waiting time, a
permanent magnet was placed adjacent to the tumor to prevent
the LPs from diffusing into the surrounding normal tissues. All
procedures using animals were conducted in accordance with
IACUC policies at The University of Texas at Austin.
2.3. MPA imaging system
The experimental setup for in vivo MPA imaging to detect the
LNPs in murine tumor is shown in Fig. 1(a). A 458-tilted mouse
imaging bed, positioned inside the water tank, was used to hold the
mouse and to keep the tumor immersed in water. During the
imaging session, the mouse was anesthetized with a combination
of isoﬂurane (0.5–2.0%) and oxygen (0.5 L/min); the waterFig. 1. (a) Block diagram of the in vivo magneto-photo-acoustic imaging system. (b) Ma
photo-acoustic imaging.temperature was kept constant at 37 8C. First, the sample was
irradiated by the laser at 800 nm to generate PA signals. The laser
source used in the experiments was a tunable optical parametric
oscillator (OPO) laser system (Spectra-Physics, 400–2600 nm
wavelength range, 5–7 ns pulse duration, up to 10 Hz pulse
repetition frequency). Speciﬁcally, PA signals were generated by a
laser light at 800 nm wavelength delivered through a 10.0 mm
diameter air-beam, which gave 17 mJ/cm2 ﬂuence at the skin
surface, satisfying the American National Standards Institute
(ANSI) safety limit of 20 mJ/cm2 for any visible/NIR wavelength
[34]. The PA signals were detected using Vevo 2100 ultrasound
imaging system (VisualSonics Inc.) equipped with a 128 element
linear array transducer (MS250, VisualSonics Inc.) operating at
21 MHz central frequency. The ultrasound array transducer had
13–24 MHz bandwidth, 15 mm geometric focal length, 75 mm
axial resolution, and 165 mm lateral resolution. The US transducer
was placed on the top of the imaged sample, 15.0 mm away from
the center of the tumor. The ultrasound system was synchronized
with the pulsed laser and, therefore, to acquire PA signals. After PA
signals were captured, the US pulses were transmitted by the same
ultrasound transducer, and the backscattered US echo signals were
detected from the same tissue cross-section. The PA and US signals
were averaged 5 times to enhance signal-to-noise ratio (SNR). The
laser was operated at the pulse repetition rate of 10 Hz. Therefore,
the acquisition time for PA and US imaging was 500 ms. After PA
and MMUS signals obtained, a pulsed magnetic ﬁeld (40 ms
duration) was applied for MMUS imaging. An electromagnet
solenoid (S1030.0, Solen Inc.) driven by a high power ampliﬁer
(7796 power ampliﬁer, AE Techron) was used to generate the
excitation magnetic ﬁeld in our experiments. The outer diameter,
inner diameter and height of the solenoid were 204 mm, 102 mm
and 51 mm, respectively. A custom-built cone-shaped iron core,
made of ferritic stainless steel, was embedded into the center of the
coil to maximize the magnetic ﬂux density at its tip. The magnetic
ﬂux density (B) at the tip of the iron core embedded within the
solenoid was measured using a digital gaussmeter equipped with a
hall-effect magnetic sensor (DSP 475, Lakeshore Inc.) and it was
approximately 1 T. The distance between the magnetic solenoid
and the tumor was approximately 3.9 mm. The strength of the
magnetic ﬁeld in the tumor region was approximately 0.8 T. To
track magnetically induced motion, ultrasound frames weregneto-photo-acoustic image formation algorithm. (c) Timing diagram of magneto-
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121 Hz frame rate by the same ultrasound transducer and
imaging system. The magnetically induced displacement was
detected using a block-matching motion tracking algorithm
based on cross-correlation estimation [35]. A total of 100 US
frames were acquired to track the MMUS signal, in which 24
frames were acquired before the application of magnetic ﬁeld.
Considering the 121 Hz frame rate of the US transducer, the total
acquisition time for MMUS imaging was 826 ms. The timing
diagram of PA, US, and MMUS imaging is shown in Fig. 1(c). The
US frames before application of magnetic ﬁeld were used as the
stationary reference. For each pixel within the image, a small
kernel was selected, and the temporal behavior of the displace-
ment was calculated by estimating the cross-correlation
between the reference kernel and the kernels within the search
region in the images acquired after the magnetic ﬁeld applica-
tion. The maximum displacement at each point was used to form
the MMUS image. To minimize the inﬂuence of physiological
motion, the US frames were acquired during the rest period
between the respiratory cycles. Furthermore, the motion of the
water tank, which represented the entire animal induced by the
physiological motion and the mechanical vibration of the
system, was measured as the baseline of our system. Then
baseline displacement calculated from the water tank was
subtracted from the measured displacement. After obtaining the
2D US, PA and MMUS images from a particular cross-section, the
water tank was step-wise translated in the lateral direction
(perpendicular to the laser beam) to image another cross-
section. The step size of the translation was around 0.5 mm.
Overall, the animal model was scanned by 6.5 mm to obtain 3D
images of the tumor. Given that the same ultrasound transducer
was used to acquire US, PA and MMUS signals using integrated
system shown in Fig. 1(a), all images were spatially co-registered
and temporally consecutive.Fig. 2. (a) Ultrasound image of a cross-section in the tumor-bearing mouse, where the tum
laterally. (b) Photoacoustic image overlaid on top of the ultrasound image. (c) Photoacou
and in the background tissue (Region II, marked with green dashed line). Photoacousti2.4. MPA image formation
The formation algorithm of MPA imaging was shown in
Fig. 1(b). Given the strong superparamagnetic property of Fe3O4
NPs and the weakly diamagnetic property of normal tissues, the
pulsed magnetic ﬁeld would only induce detectable displacement
in the regions containing LNPs. However, in animal studies, the
physiological motions from cardiac and respiratory systems,
together with the mechanical vibration of the system, can
introduce unwanted background motion and cause noises in
MMUS image. The experiments were designed to acquire data
during the rest period with low respiratory motion; and the
magnetically induced motion was typically 14 dB (5 times) larger
than the background motion. A binary motion map was obtained
by setting a displacement threshold (around 20% of the maximum
displacement) in MMUS image. In this binary motion map, the
MMUS signals over the threshold were assumed to be produced by
magnetic ﬁeld and the value was set to ‘‘1’’, while the MMUS
signals below the threshold were set to ‘‘0’’. The binary motion
map, therefore, was indicative of the locations of LNPs, and can be
used as a mask to identify the PA signals from the LNPs. By
multiplying the PA image with the MMUS-derived binary motion
map, the PA signals generated from NPs were identiﬁed; while the
PA signals from the background tissue were highly suppressed.
Therefore, the obtained MPA image can show the distribution of
nanoparticles in tissue with enhanced contrast.
3. Results and discussion
The cross-section of the tumor and its anatomical structure
were visible in the B-mode US image (Fig. 2(a)). The PA image
(Fig. 2(b)) indicates that the PA signals were detected from both the
tumor containing NPs and the background tissue. Strong PA signals
in the tumor were generated from the light absorption by theor is marked with yellow dash lines. The image covers 10.9 mm axially and 11.0 mm
stic signals obtained in the LNP-loaded tumor (Region I, marked with blue solid line)
c signals were displayed along the dashed lines in (b).
Fig. 3. (a) Magneto-motive ultrasound image of a cross-section in the tumor-bearing mouse. The image covers 10.9 mm axially and 11.0 mm laterally. (b) Temporal
displacement curves from both the LNP-loaded tumor (Region I, marked with blue solid line) and the background tissue (Region II, marked with green dashed line). The
magnetic ﬁeld is shown in the insert.
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detected from the background tissue due to the absorption of
endogenous chromophores, which reduced the contrast speciﬁcity
in detecting the LNPs in the animal model. The PA signal amplitude
from the tumor and the background tissue are shown in Fig. 2(c).
The dashed line in Fig. 2(b) shows the location of the displayed PA
signals. The average PA signal amplitude from the tumor
containing LNPs (Region I) was 8.44 dB stronger than that from
the background tissue (Region II).
The MMUS image shows that the pulsed magnetic ﬁeld induced
a displacement inside the tumor as a result of the LNPs’ strong
magnetization (Fig. 3(a)). Conversely, the background tissue
regions did move coherently during the application of the
magnetic ﬁeld because of the low magnetic susceptibility inherent
to tissue. The temporal displacement curves from both the tumor
containing LNPs (Region I) and the background tissue (Region II)
are shown in Fig. 3(b), in which the time function of the magnetic
ﬁeld is displayed in the insert. The magnetic ﬁeld was applied for
40 ms while the magnetically induced motion lasted for longer
time. The maximum displacement in the LNP-loaded tumor was
20.3 mm. In contrast, the maximum displacement in the back-
ground tissue was around 3.0 mm – this motion is likely due to
mechanical vibration of the system and/or physiological motion.
The maximum displacement from the NP-loaded tumor was more
than 6-fold greater than that from the background tissue, resulting
in MMUS imaging contrast of 16.5 dB. In the MMUS image shown
in Fig. 3(a), the displacement has a gradient from the free edge toFig. 4. (a) Magneto-photo-acoustic image of a cross-section in the tumor-bearing mou
acoustic signals obtained in the LNP-loaded tumor (Region I, marked with blue solid line
signal amplitude from the background tissue (Region II) was completely suppressed.the base of the tumor because the mechanical boundary condition
of the tumor affected the mechanical response.
In MPA imaging, the magnetically induced motion was applied
to differentiate the sources of PA signals. Although the background
tissues generated noticeable PA signals due to their optical
absorption, they did have detectable response to the magnetic
excitation. Therefore, the MMUS signal can suppress the unwanted
PA signals from the background tissue, and, therefore, to improve
the imaging contrast. A 4 mm threshold was applied to the MMUS
image to produce a binary motion map, in which the MMUS signals
over 4 mm was set as ‘‘1’’, otherwise set as ‘‘0’’. The MPA image was
obtained by masking the PA image using the binary motion map.
Figure 4 shows the MPA image and signals from different regions.
As shown in Fig. 4(a), the tumor containing LNPs is identiﬁed in the
MPA image with high contrast and clear boundary. From Fig. 4(b),
the MPA signal from the background tissue (Region II) was
completely suppressed. Compared to the PA image shown in Fig. 2,
MPA imaging signiﬁcantly improved the contrast between the NP-
loaded tumor and the background tissue; and maintained the
sensitivity of PA imaging to the NP concentration variation within
the tumor. Therefore, by applying MMUS image as a mask on PA
image, the MPA imaging can detect the distribution of the
accumulated NPs in vivo with high contrast.
The 3D images were constructed from 14 imaged cross sections
using Amira. The distance between each cross section was 0.5 mm.
The 3D images cover 10.9 mm axially, 11.0 mm laterally, and a
6.5 mm scanning distance. The 3D US image shown in Fig. 5(a)se. The image covers 10.9 mm axially and 11.0 mm laterally. (b) Magneto-photo-
) and in the background tissue (Region II, marked with green dashed line). The MPA
Fig. 5. 3D (a) ultrasound, (b) photoacoustic, (c) magneto-motive ultrasound, and (d) magneto-photo-acoustic images of the LNP-loaded tumor and the background tissue in a
mouse. The images cover 10.9 mm axially, 11.0 mm laterally with a 6.5 mm scanning distance.
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(Fig. 5(b)), signiﬁcant signals were generated not only from the
tumor containing LNPs, but also from the background tissue. The
background PA signals limited the contrast for LNPs, and decreased
the speciﬁcity of PA imaging to differentiate between the
background tissue and the nanoparticles used to target tumor.
Furthermore, the sensitivity of detecting the tumor was also
limited because a larger concentration of LNPs was needed to
exceed the level of the signal produced by the background. To
improve the sensitivity and speciﬁcity of tumor detection, the 3D
MMUS image shown in Fig. 5(c) was used to mask the 3D PA image,
resulting in a 3D MPA image shown in Fig. 5(d). The MPA image
enhanced the contrast between the LNPs and the background
tissue, providing accurate positioning information on the tumor in
the mouse model.
PA imaging is capable of visualizing the optical absorbers in
tissues with a penetration depth up to several centimeters. In an in
vivo environment, the endogenous absorber reduces the contrast
of nanoparticle-mediated PA imaging, even in the NIR wavelength
range. On the other hand, MMUS signals are selectively generated
from the magnetic NPs because tissue is a weakly diamagnetic
medium whose mechanical response to magnetic excitation is
negligible. Thus MMUS imaging can differentiate tissues loaded
with NPs from the background tissues with sufﬁcient contrast.
However, due to continuum mechanics, MMUS imaging is not
sensitive to the local concentration variation of the NPs. Thus
MMUS imaging alone is limited to visualize the local distribution of
NPs in the tumor. We applied a multi-modal imaging technique,
MPA imaging, to detect the LNP distribution in a tumor in vivo with
high sensitivity and speciﬁcity by masking PA image with co-
registered MMUS image. In MPA image, the PA signal would be
retained only if the corresponding MMUS signal is signiﬁcantly
larger than background motion, which is generated from the
external mechanical vibration and the physiological motion. Inagreement with the theoretical expectations, MPA imaging has
been proved to be efﬁcient in suppressing the unwanted signals
from the background tissue. Thus MPA imaging can enhance the
contrast signiﬁcantly, and therefore, enable high-sensitivity and
high-speciﬁcity detection of the distribution of LNPs.
MMUS imaging provided a reliable and accurate mask for PA
image, thus generating sufﬁcient contrast in MPA imaging. First,
the Fe3O4 NPs in the LNPs exhibited magnetic susceptibility more
than 6 orders of magnitude higher than normal tissue. Thus, under
the excitation of an external magnetic ﬁeld, the magneto-motive
forces were only produced in the locations containing LNPs.
Consequently, using magnetically induced motion as the mask, the
PA signals from LNPs were safely retained, while undesired signals
from the background tissue were reliably suppressed. Because the
LNPs used in our study contained both magnetic and plasmonic
components, the MMUS and PA images from the LNP were spatially
co-registered. Therefore, the MMUS imaging mask was spatially
accurate for PA signals. However, the noise motion in MMUS
imaging, from either mechanical vibration of the imaging system
or physiological motion of the animal, can interfere with the
magnetically induced motion from LNPs and limit the contrast to
noise ratio in MPA imaging. An algorithm has been developed to
compensate for the noise motion using a priori information from
ﬁnite element method models of the response of soft tissue to a
pulsed radiation force [36]. By applying similar compensation
algorithm, the noise motion level can be reduced, and the MPA
imaging contrast could be further improved.
In the in vivo experiment, LNPs were injected directly into the
tumor to act as the dual-contrast agent. We injected 150 mL LNPs
containing 0.35 mg Au nanorods (9 nm diameter by 30 nm
length) and 0.33 mg Fe3O4 nanospheres (7.5 nm diameter). Thus
the tumor in the studied mouse contained 9.5  1012 Au NRs and
1.66  1014 Fe3O4 NPs in the imaged region. From the results, the
MPA imaging is sensitive enough to identify the pathologies
M. Qu et al. / Photoacoustics 2 (2014) 55–62 61labeled with 1012 Au NRs and 1014 Fe3O4 NPs. From the in vivo
studies in the literature, it is possible to accumulate more than 1013
gold nanorods [37] and around 1014 Fe3O4 NPs [38,39] in the tumor
region through intravenous tail vein injection. Therefore, the
sensitivity of MPA imaging is sufﬁcient for in vivo study with
systemic administration of administration of NPs.
4. Conclusion
In conclusion, MPA imaging of the hybrid LNPs in a
subcutaneous tumor of a nude mouse was obtained under in vivo
condition. Based on both optical and magnetic responses of LNPs,
MPA imaging was capable of noninvasively detecting the
distribution of LNPs in tumor with enhanced contrast. The PA
signals were produced from the LNPs in tumor based on the
interaction between the LNPs’ Au NRs and the pulsed laser.
However, signiﬁcant PA signals were also generated from the
background tissue due to the presence of endogenous chromo-
phores. The background signals reduced the sensitivity and
speciﬁcity of the nanoparticle detection. In MPA imaging, the PA
signals were masked by the MMUS-derived motion map. Due to
the difference in the magnetic susceptibility between the Fe3O4
NPs inside LNPs and the tissue, the MMUS signals were only
generated from the regions containing LNPs. Using the magneti-
cally induced motion map as a mask, the PA signals from the
background tissue were strongly suppressed, while the signals
from the tumor containing LNPs were retained. Therefore, MPA
imaging signiﬁcantly enhanced the contrast between the LNPs,
which were used to label the tumor, and the native tissues;
enabled high-sensitivity and high-speciﬁcity detection of the
tumor in vivo. In addition, MPA imaging retained the sensitivity of
PA imaging to the concentration variation of nanoparticles,
providing an excellent potential for molecular imaging applica-
tions such as the detection of physiological processes and the
guidance of targeted therapies.
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